Showing results (561-570 of 2,384) with videos related to
Sort By:
Pageof 239
Gene|February 28, 2002
Murine Tbx2 contains domains that activate and repress gene transcriptionChristian Paxton, Honghua Zhao, Yvette Chin, et al.Journal of Pediatric Surgery|January 1, 1997
Does calcitonin gene-related peptide act as a chemoattractant for rat gubernacular cells?Y Sugita, G A Paxton, S Hasthorpe, et al.Cultural Diversity & Ethnic Minority Psychology|June 16, 2025
Exploring the role of ethnic identity and coping on depressive symptoms in Black and Latinx college students after discriminationSusan Torres-Harding, Lauryn D Bergert, Jessica Paxton, et al.Journal of Addiction Medicine|August 22, 2025
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi TechniqueNicole Malette, Gurkiran Parmar, Josey Ross, et al.Drugs & Aging|April 13, 2002
Thalidomide in cancer treatment: a potential role in the elderly?Shufeng Zhou, Philip Kestell, Malcolm D Tingle, et al.Acta Psychiatrica Scandinavica|November 17, 2009
Incidence and diagnostic diversity in first-episode psychosisR Reay, E Mitford, K McCabe, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|June 22, 2001
Determination of unbound concentration of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in human plasma by ultrafiltration followed by high-performance liquid chromatography with fluorimetric detectionS Zhou, J W Paxton, M D Tingle, et al.The Journal of Pharmacy and Pharmacology|May 9, 2001
Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various speciesS Zhou, J W Paxton, P Kestell, et al.Biochemical Pharmacology|December 11, 2002
Preclinical factors influencing the relative contributions of Phase I and II enzymes to the metabolism of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acetic acidShufeng Zhou, Philip Kestell, Bruce C Baguley, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000
Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acidS Zhou, J W Paxton, M D Tingle, et al.Pageof 239